专利检索 ap:("YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD." OR "HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.") AND inv:"Nurit BEYTH" 第 1 页

1.

发明申请
PHAGE THERAPY FOR TARGETING ENTEROCOCCI 审中-公开

公开(公告)号：US20170281700A1

公开(公告)日：2017-10-05

申请号：US15623556

申请日：2017-06-15

申请人： YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. , HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.

发明人： Nissan Ronen HAZAN , Nurit BEYTH

IPC分类号： A61K35/76 , A61K9/00 , C12N7/00 , A61K45/06

CPC分类号： A61K35/76 , A61K9/0034 , A61K45/06 , C12N7/00 , C12N2795/10121 , C12N2795/10132 , C12N2795/10171

摘要： Isolated bacteriophages having genomes comprising the nucleic acid sequences as set forth in SEQ ID NOs: 1 and 2, or variants thereof, and compositions comprising the bacteriophages in a ratio ranging from 1:10 to 10:1, respectively. Further provided are uses of the compositions in treating or preventing an infection inflicted by a bacteria (e.g., Enterococcous faecalis and/or Enterococcous faecium). As a non-limiting example, the composition may be used in treating or preventing a root canal infection.